Literature DB >> 1632569

Comparison of three progressive exercise protocols in peripheral vascular occlusive disease.

A W Gardner1, J S Skinner, N R Vaughan, C X Bryant, L K Smith.   

Abstract

Although claudication pain and hemodynamic responses to exercise are usually clinically assessed via graded treadmill walking, measuring these responses to other commonly performed tasks may yield a more nearly complete evaluation of peripheral vascular occlusive disease. Thus, the purpose of this study was twofold: (1) to determine the reliability of claudication and hemodynamic responses to level walking and stairclimbing and (2) to compare these responses with those obtained with graded walking at similar oxygen consumption. Ten patients with stable claudication symptoms performed graded walking, level walking, and stairclimbing progressive protocols with respective increases in grade, walking speed, and stepping rate on a modified stairclimbing device every two minutes. Similar peak oxygen consumption (13.60 to 14.18 mL/kg/min) was attained with the three protocols (P = NS). Reliability coefficients for the times to onset and to maximal claudication pain during level walking (R = 0.95 and 0.95, respectively) and during stairclimbing (R = 0.92 and 0.82, respectively) were similar to those previously obtained during graded walking. Reliability coefficients for foot transcutaneous oxygen tension during and following level walking (R = 0.78 to 0.96) and stairclimbing (R = 0.65 to 0.98) and for ankle systolic blood pressure following level walking (R = 0.95 to 0.97) and stairclimbing (R = 0.90 to 0.98) were also similar to those previously found with graded walking. Additionally, claudication and hemodynamic measurements were similar among the three exercise protocols. Thus, because graded walking, level walking, and stairclimbing progressive exercise protocols yield reliable and similar information about the hemodynamic severity of peripheral vascular occlusive disease, only one is needed for evaluation.

Entities:  

Mesh:

Year:  1992        PMID: 1632569     DOI: 10.1177/000331979204300806

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

1.  Walking economy before and after the onset of claudication pain in patients with peripheral arterial disease.

Authors:  Andrew W Gardner; Raphael M Ritti-Dias; Julie A Stoner; Polly S Montgomery; Kristy J Scott; Steve M Blevins
Journal:  J Vasc Surg       Date:  2010-03       Impact factor: 4.268

2.  Dietary intake of participants with peripheral artery disease and claudication.

Authors:  Andrew W Gardner; Brianna C Bright; Kelly A Ort; Polly S Montgomery
Journal:  Angiology       Date:  2011-04       Impact factor: 3.619

3.  Gender differences in daily ambulatory activity patterns in patients with intermittent claudication.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Aman Khurana; Raphael M Ritti-Dias; Steve M Blevins
Journal:  J Vasc Surg       Date:  2010-08-08       Impact factor: 4.268

4.  Oxygen uptake before and after the onset of claudication during a 6-minute walk test.

Authors:  Andrew W Gardner; Raphael M Ritti-Dias; Julie A Stoner; Polly S Montgomery; Aman Khurana; Steve M Blevins
Journal:  J Vasc Surg       Date:  2011-09-03       Impact factor: 4.268

5.  The effect of claudication pain on temporal and spatial gait measures during self-paced ambulation.

Authors:  Andrew W Gardner; Polly S Montgomery; Raphael M Ritti-Dias; Larry Forrester
Journal:  Vasc Med       Date:  2009-09-25       Impact factor: 3.239

6.  Resting energy expenditure in subjects with and without intermittent claudication.

Authors:  Andrew W Gardner; Polly S Montgomery
Journal:  Metabolism       Date:  2009-07       Impact factor: 8.694

7.  The effect of metabolic syndrome components on exercise performance in patients with intermittent claudication.

Authors:  Andrew W Gardner; Polly S Montgomery
Journal:  J Vasc Surg       Date:  2008-04-14       Impact factor: 4.268

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.